Tivorsan Pharmaceuticals, Inc. today announced that Justin Fallon, PhD – Corporate Director, Founding Scientist and Brown University Professor – will present at next week’s Biotech Showcase™ 2015 in San Francisco, CA. Dr. Fallon will provide a company overview as well as the scientific rationale behind recombinant biglycan (TVN-102) as a disease-modifying treatment candidate for Duchenne Muscular Dystrophy and other progressive neuromuscular disorders.
Help employers find you! Check out all the jobs and post your resume.
